Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population

Table 2 Allele and genotype frequencies of the MYO9B SNPs rs962917 in inflammatory bowel disease patients vs controls, n (%)

	Control (n = 402)	IBD (n = 442)			CD (n = 207)			UC (n = 235)
			OR (95%CI)	Pcorr		OR (95%CI)	Pcorr		OR (95%CI)	Pcorr
GF
CC	27 (6.6)	38 (8.6)	1.23 (0.79-1.65)	0.64	21 (10.1)	1.52 (0.63-2.17)	0.09	17 (7.2)	1.09 (0.82-1.40)	0.75
CT	173 (42.5)	163 (36.9)	0.87 (0.52-1.24)	0.26	79 (38.2)	0.81 (0.47-1.33)	0.24	84 (35.8)	0.83 (0.69-1.14)	0.31
TT	207 (50.9)	241 (54.5)	1.07 (0.82-1.41)	0.97	107 (51.7)	1.02 (0.85-1.24)	0.83	134 (57.0)	1.12 (0.67-1.46)	0.48
AF
C	227 (27.9)	239 (27.0)	0.92 (0.66-1.71)	0.52	121 (29.2)	1.06 (0.75-1.41)	0.66	118 (25.1)	0.86 (0.67-1.35)	0.38
T	587 (72.1)	645 (73.0)	1.02 (0.81-1.30)	0.77	293 (70.8)	0.98 (0.61-1.59)	0.49	352 (74.9)	1.14 (0.82-1.33)	0.29

IBD: Inflammatory bowel disease; GF: Genotype frequencies; AF: Allele frequencies; OR: Odds ratio; CI: Confidence interval; SNP: Single nucleotide polymorphism; CD: Crohn’s disease. Genotype and allele frequencies in patients and controls were compared using the χ² test; P_corr: Corrected P value.